The results of xelox (capecitabine plus oxaliplatin) in metastatic colorectal cancer: A single center experience

被引：0
|
作者：
Yaman, Emel [1 ]
Yildiz, Ramazan [1 ]
Kaya, A. Osman [1 ]
Ozturk, Banu [1 ]
Buyukberber, Suleyman [1 ]
Coskun, Ugur [1 ]
Benekli, Mustafa [1 ]
Yamac, Deniz [1 ]
Uner, Aytug [1 ]
机构：
[1] Gazi Med Fac, Ankara, Turkey
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：129 / 129
页数：1
相关论文
共 50 条
  • [21] Phase II study of capecitabine plus oxaliplatin (XELOX) followed by capecitabine plus irinotecan (XELIRI) in a sequential schedule in first-line metastatic colorectal cancer (MCRC)
    Cassinello, Javier
    Alvarez, Jose V.
    Garcia Lopez, Maria J.
    Pujol, Eduardo
    Colmenarejo, Antonio
    De Segovia, Fernando
    Marcos, Fernando
    Filipovich, Elena
    Arcediano, Alberto
    Garcia Castro, Ines
    ANNALS OF ONCOLOGY, 2006, 17 : 116 - 117
  • [22] Short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: Results of the phase II xelquali study
    Waddell, T.
    Gollins, S.
    Soe, W.
    Valle, J.
    Allen, J.
    Bentley, D.
    Morris, J.
    Lloyd, A.
    Swindell, R.
    Saunders, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 79 - 79
  • [23] Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer
    Ducreux, Michel
    Bennouna, Jaafar
    Hebbar, Mohamed
    Ychou, Marc
    Lledo, Gerard
    Conroy, Thierry
    Adenis, Antoine
    Faroux, Roger
    Rebischung, Christine
    Bergougnoux, Loic
    Kockler, Leila
    Douillard, Jean-Yves
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (03) : 682 - 690
  • [24] Capecitabine plus oxaliplatin for the treatment of colorectal cancer
    Carrato, Alfredo
    Gallego-Plazas, Javier
    Guillen-Ponce, Carmen
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (02) : 161 - 174
  • [25] Comparative study of metronomic capecitabine and oxaliplatin versus classic XELOX in Egyptian patients with metastatic colorectal cancer
    Abu El Ela, R. Y.
    El-Serafy, M. M.
    Ismail, M. Y.
    Shouman, S. A. S.
    Omran, M. M.
    Allam, R.
    ANNALS OF ONCOLOGY, 2020, 31 : S435 - S435
  • [26] Comparative study of metronomic capecitabine and oxaliplatin versus classic XELOX in Egyptian metastatic colorectal cancer patients
    Abu El-Ela, Raghda Y.
    El-Serafy, Mostafa M.
    Yahia, Maha
    Omran, Mervat M.
    Allam, Rasha
    Shouman, Samia A.
    MEDICAL SCIENCE, 2020, 24 (105) : 3041 - 3050
  • [27] OXALIPLATIN AND CAPECITABINE (XELOX) PLUS BEVACIZUMAB (BEVA) FOR ELDERLY PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (mCRC): BOXE, A PHASE II TRIAL
    Rosati, Gerardo
    Cordio, Stefano
    Leo, Silvana
    Daniele, Bruno
    Butera, Alfredo
    ANNALS OF ONCOLOGY, 2011, 22 : v104 - v104
  • [28] Phase I/II Study of Capecitabine Plus Oxaliplatin (XELOX) Plus Bevacizumab As First-line Therapy in Japanese Patients with Metastatic Colorectal Cancer
    Doi, Toshihiko
    Boku, Narikazu
    Kato, Ken
    Komatsu, Yoshito
    Yamaguchi, Kensei
    Muro, Kei
    Hamamoto, Yasuo
    Sato, Atsushi
    Koizumi, Wasaburo
    Mizunuma, Nobuyuki
    Takiuchi, Hiroya
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (10) : 913 - 920
  • [29] Biweekly XELOX (capecitabine and oxaliplatin) as first-line treatment in elderly patients with metastatic colorectal cancer
    Grande, Carlos
    Quintero, Guillermo
    Candamio, Sonia
    Paris Bouzas, Lorena
    Jose Villanueva, Maria
    Campos, Begona
    Gallardo, Elena
    Alvarez, Elena
    Casal, Joaquin
    Ramon Mel, Jose
    JOURNAL OF GERIATRIC ONCOLOGY, 2013, 4 (02) : 114 - 121
  • [30] OXALIPLATIN PLUS CAPECITABINE (XELOX) AS FIRST-LINE CHEMOTHERAPY FOR ELDERLY PATIENTS WITH ADVANCED GASTRIC CANCER: RESULTS OF A MONOCENTRIC EXPERIENCE
    Rozzi, A.
    Corona, M.
    Nardoni, C.
    Restuccia, M.
    Lanzetta, G.
    ANNALS OF ONCOLOGY, 2009, 20 : 90 - 90
12345